tiprankstipranks
VitaSpring Biomedical (VSBC)
OTHER OTC:VSBC
US Market

VitaSpring Biomedical (VSBC) Income Statement

2 Followers

VitaSpring Biomedical Income Statement

Last quarter (Q ), VitaSpring Biomedical's total revenue was $―, a decrease of -100.00% from the same quarter last year. In Q, VitaSpring Biomedical's net income was $-182.31K. See VitaSpring Biomedical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Jan 22Jan 21Jan 20Jan 19Jan 18
Total Revenue
$ 4.98M$ 5.61M$ 248.20K$ 15.14K$ 17.18K$ 16.23K
Cost of Revenue
$ 2.94M$ -3.55M$ -136.00K$ 13.45K$ 3.46K$ 4.89K
Gross Profit
$ 2.04M$ 2.07M$ 112.20K$ 1.70K$ 13.72K$ 11.34K
Operating Expense
$ 859.57K$ 586.89K$ 537.58K$ 21.18K$ 35.84K$ 17.71K
Operating Income
$ 1.18M$ 3.55M$ -313.18K$ -19.49K$ -22.12K$ -6.37K
Net Non Operating Interest Income Expense
$ -797.00--$ 0.00--
Other Income Expense
$ -349.52K--$ 26.41K$ -279.00-
Pretax Income
$ 1.54M$ 3.55M$ -313.18K$ 6.92K$ -22.40K$ -6.37K
Tax Provision
$ 337.14K$ 217.10K$ -93.93K$ 0.00$ 0.00$ 0.00
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ 1.07M$ 3.33M$ -313.18K$ 6.92K$ -22.40K$ -6.37K
Basic EPS
$ <0.01--$ <0.01$ >-0.01$ >-0.01
Diluted EPS
$ <0.01--$ <0.01$ >-0.01$ >-0.01
Basic Average Shares
$ 826.09M$ 205.98M$ 91.09M$ 54.51M$ 54.51M$ 54.51M
Diluted Average Shares
$ 619.57M-$ 91.09M$ 54.51M$ 54.51M$ 54.51M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
$ 92.34K--$ 5.17K$ 5.64K-
Total Expenses
$ 3.80M$ -2.96M$ 401.58K$ 34.63K$ 39.30K$ 22.60K
Net Income From Continuing And Discontinued Operation
$ 1.11M$ 3.33M$ -313.18K$ 6.92K$ -22.40K$ -6.37K
Normalized Income
$ 1.22M--$ -10.46K$ -22.12K$ -6.37K
Interest Expense
------
EBIT
$ 1.53M$ 3.55M$ -313.18K$ -19.49K$ -22.12K$ -6.37K
EBITDA
$ 1.55M$ 3.56M$ -313.18K$ -19.04K$ -21.67K$ -6.00K
Currency in USD

VitaSpring Biomedical Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis